{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:01:34Z","timestamp":1762300894038,"version":"3.40.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,7]]},"DOI":"10.7759\/cureus.81828","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T13:18:34Z","timestamp":1744031914000},"source":"Crossref","is-referenced-by-count":1,"title":["Multidisciplinary Management of Aggressive Orbital Rhabdomyosarcoma in an Adult Patient: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Leila","family":"Afani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Baladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazih","family":"Assabban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassine","family":"Benchamkha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhizlane","family":"Belbaraka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2011.10.007","article-title":"Update on rhabdomyosarcoma","volume":"21","author":"Dasgupta R","year":"2012","unstructured":"Dasgupta R, Rodeberg DA. Update on rhabdomyosarcoma. Semin Pediatr Surg. 2012, 21:68-78. 10.1053\/j.sempedsurg.2011.10.007","journal-title":"Semin Pediatr Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11550","article-title":"Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution","volume":"98","author":"Ferrari A","year":"2003","unstructured":"Ferrari A, Dileo P, Casanova M, et al.. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003, 98:571-80. 10.1002\/cncr.11550","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9948885","article-title":"Rhabdomyosarcoma in adults: a retrospective analysis of case records diagnosed between 1979 and 2018 in Western Denmark","volume":"2021","author":"M\u00e4kinen VN","year":"2021","unstructured":"M\u00e4kinen VN, Safwat A, Aggerholm-Pedersen N. Rhabdomyosarcoma in adults: a retrospective analysis of case records diagnosed between 1979 and 2018 in Western Denmark. Sarcoma. 2021, 2021:9948885. 10.1155\/2021\/9948885","journal-title":"Sarcoma"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7483","article-title":"Comparing adult and pediatric rhabdomyosarcoma in the Surveillance, Epidemiology, and End Results program, 1973 to 2005: an analysis of 2,600 patients","volume":"27","author":"Sultan I","year":"2009","unstructured":"Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A. Comparing adult and pediatric rhabdomyosarcoma in the Surveillance, Epidemiology, and End Results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol. 2009, 27:3391-7. 10.1200\/JCO.2008.19.7483","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5858\/2006-130-1454-RIAACA","article-title":"Rhabdomyosarcomas in adults and children: an update","volume":"130","author":"Parham DM","year":"2006","unstructured":"Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med. 2006, 130:1454-65. 10.5858\/2006-130-1454-RIAACA","journal-title":"Arch Pathol Lab Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(02)00415-0","article-title":"Rhabdomyosarcoma: review for the ophthalmologist","volume":"48","author":"Shields JA","year":"2003","unstructured":"Shields JA, Shields CL. Rhabdomyosarcoma: review for the ophthalmologist. Surv Ophthalmol. 2003, 48:39-57. 10.1016\/s0039-6257(02)00415-0","journal-title":"Surv Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2013.06.004","article-title":"Orbital rhabdomyosarcomas: a review","volume":"27","author":"Jurdy L","year":"2013","unstructured":"Jurdy L, Merks JH, Pieters BR, Mourits MP, Kloos RJ, Strackee SD, Saeed P. Orbital rhabdomyosarcomas: a review. Saudi J Ophthalmol. 2013, 27:167-75. 10.1016\/j.sjopt.2013.06.004","journal-title":"Saudi J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2023.05.032","article-title":"Orbital rhabdomyosarcoma in a 19-year-old male patient: a case report and literature review","volume":"18","author":"Nhung TH","year":"2023","unstructured":"Nhung TH, Minh VL, Tuyet TT, et al.. Orbital rhabdomyosarcoma in a 19-year-old male patient: a case report and literature review. Radiol Case Rep. 2023, 18:2744-9. 10.1016\/j.radcr.2023.05.032","journal-title":"Radiol Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S44582","article-title":"Rhabdomyosarcoma in adolescent and young adult patients: current perspectives","volume":"5","author":"Egas-Bejar D","year":"2014","unstructured":"Egas-Bejar D, Huh WW. Rhabdomyosarcoma in adolescent and young adult patients: current perspectives. Adolesc Health Med Ther. 2014, 5:115-25. 10.2147\/AHMT.S44582","journal-title":"Adolesc Health Med Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102376","article-title":"Orbital tumors\u2014clinical, radiologic and histopathologic correlation","volume":"12","author":"Vogele D","year":"2022","unstructured":"Vogele D, Sollmann N, Beck A, et al.. Orbital tumors\u2014clinical, radiologic and histopathologic correlation. Diagnostics (Basel). 2022, 12:2376. 10.3390\/diagnostics12102376","journal-title":"Diagnostics (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0025","article-title":"Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"von Mehren M","year":"2018","unstructured":"von Mehren M, Randall RL, Benjamin RS, et al.. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018, 16:536-63. 10.6004\/jnccn.2018.0025","journal-title":"J Natl Compr Canc Netw"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143567","article-title":"Radiation therapy in the treatment of head and neck rhabdomyosarcoma","volume":"13","author":"Frankart AJ","year":"2021","unstructured":"Frankart AJ, Breneman JC, Pater LE. Radiation therapy in the treatment of head and neck rhabdomyosarcoma. Cancers (Basel). 2021, 13:3567. 10.3390\/cancers13143567","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12079-y","article-title":"Adult head and neck rhabdomyosarcoma: radiotherapy-based treatment, outcomes, and predictors of survival","volume":"24","author":"Zhao D","year":"2024","unstructured":"Zhao D, Zhou F, Liu W, et al.. Adult head and neck rhabdomyosarcoma: radiotherapy-based treatment, outcomes, and predictors of survival. BMC Cancer. 2024, 24:340. 10.1186\/s12885-024-12079-y","journal-title":"BMC Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215269","article-title":"Rhabdomyosarcoma: current therapy, challenges, and future approaches to treatment strategies","volume":"15","author":"Zarrabi A","year":"2023","unstructured":"Zarrabi A, Perrin D, Kavoosi M, et al.. Rhabdomyosarcoma: current therapy, challenges, and future approaches to treatment strategies. Cancers (Basel). 2023, 15:5269. 10.3390\/cancers15215269","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.3768","article-title":"Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803","volume":"27","author":"Arndt CA","year":"2009","unstructured":"Arndt CA, Stoner JA, Hawkins DS, et al.. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol. 2009, 27:5182-8. 10.1200\/JCO.2009.22.3768","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.4469","article-title":"Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"29","author":"Raney RB","year":"2011","unstructured":"Raney RB, Walterhouse DO, Meza JL, et al.. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol. 2011, 29:1312-8. 10.1200\/JCO.2010.30.4469","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30617-5","article-title":"Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Bisogno G","year":"2019","unstructured":"Bisogno G, De Salvo GL, Bergeron C, et al.. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2019, 20:1566-75. 10.1016\/S1470-2045(19)30617-5","journal-title":"Lancet Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10669","article-title":"Adult rhabdomyosarcoma: outcome following multimodality treatment","volume":"95","author":"Little DJ","year":"2002","unstructured":"Little DJ, Ballo MT, Zagars GK, et al.. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002, 95:377-88. 10.1002\/cncr.10669","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11259","article-title":"Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults","volume":"97","author":"Komdeur R","year":"2003","unstructured":"Komdeur R, Klunder J, van der Graaf WT, van den Berg E, de Bont ES, Hoekstra HJ, Molenaar WM. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults. Cancer. 2003, 97:1999-2005. 10.1002\/cncr.11259","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/334470-multidisciplinary-management-of-aggressive-orbital-rhabdomyosarcoma-in-an-adult-patient-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T13:18:35Z","timestamp":1744031915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/334470-multidisciplinary-management-of-aggressive-orbital-rhabdomyosarcoma-in-an-adult-patient-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.81828","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}